Zhang H, Xu J, Long Y, Maimaitijiang A, Su Z, Li W
Int J Mol Sci. 2024; 25(23).
PMID: 39684639
PMC: 11641486.
DOI: 10.3390/ijms252312928.
Ghate N, Kim S, Mehmood R, Shin Y, Kim K, An W
Oncogene. 2023; 42(17):1405-1416.
PMID: 37041410
PMC: 10121470.
DOI: 10.1038/s41388-023-02685-8.
Resnick-Silverman L, Zhou R, Campbell M, Leibling I, Parsons R, Manfredi J
Cell Rep. 2023; 42(3):112216.
PMID: 36924496
PMC: 10200257.
DOI: 10.1016/j.celrep.2023.112216.
Kon N, Wang D, Gu W
Cell Death Dis. 2019; 10(3):237.
PMID: 30858352
PMC: 6411979.
DOI: 10.1038/s41419-019-1484-6.
Offutt T, Ieong P, Demir O, Amaro R
Biochemistry. 2018; 57(46):6528-6537.
PMID: 30388364
PMC: 7560988.
DOI: 10.1021/acs.biochem.8b01005.
A novel dysfunctional germline P53 mutation identified in a family with Li-Fraumeni syndrome.
Ji M, Wang L, Shao Y, Cao W, Xu T, Chen S
Am J Cancer Res. 2018; 8(1):165-169.
PMID: 29416929
PMC: 5794730.
New Phage Display-Isolated Heptapeptide Recognizing the Regulatory Carboxy-Terminal Domain of Human Tumour Protein p53.
Ben Abid S, Sahnoun M, Yacoubi-Hadj Amor I, Abdelmoula-Souissi S, Hassairi H, Mokdad-Gargouri R
Protein J. 2017; 36(5):443-452.
PMID: 28710679
DOI: 10.1007/s10930-017-9730-1.
The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.
Laptenko O, Tong D, Manfredi J, Prives C
Trends Biochem Sci. 2016; 41(12):1022-1034.
PMID: 27669647
PMC: 6258061.
DOI: 10.1016/j.tibs.2016.08.011.
Full-length p53 tetramer bound to DNA and its quaternary dynamics.
Demir O, Ieong P, Amaro R
Oncogene. 2016; 36(10):1451-1460.
PMID: 27641333
PMC: 5344712.
DOI: 10.1038/onc.2016.321.
Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease?.
Costa D, de Oliveira G, Cino E, Soares I, Rangel L, Silva J
Cold Spring Harb Perspect Biol. 2016; 8(10).
PMID: 27549118
PMC: 5046694.
DOI: 10.1101/cshperspect.a023614.
The physical interaction of p53 and plakoglobin is necessary for their synergistic inhibition of migration and invasion.
Alaee M, Padda A, Mehrabani V, Churchill L, Pasdar M
Oncotarget. 2016; 7(18):26898-915.
PMID: 27058623
PMC: 5042024.
DOI: 10.18632/oncotarget.8616.
Two p53 tetramers bind one consensus DNA response element.
Kearns S, Lurz R, Orlova E, Okorokov A
Nucleic Acids Res. 2016; 44(13):6185-99.
PMID: 27034469
PMC: 5291249.
DOI: 10.1093/nar/gkw215.
Anti-Transcription Factor RNA Aptamers as Potential Therapeutics.
Mondragon E, Maher 3rd L
Nucleic Acid Ther. 2015; 26(1):29-43.
PMID: 26509637
PMC: 4753637.
DOI: 10.1089/nat.2015.0566.
Misfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer.
de Oliveira G, Rangel L, Costa D, Silva J
Front Oncol. 2015; 5:97.
PMID: 25973395
PMC: 4413674.
DOI: 10.3389/fonc.2015.00097.
Acetylation of lysine 382 and phosphorylation of serine 392 in p53 modulate the interaction between p53 and MDC1 in vitro.
Shahar O, Gabizon R, Feine O, Alhadeff R, Ganoth A, Argaman L
PLoS One. 2013; 8(10):e78472.
PMID: 24194938
PMC: 3806821.
DOI: 10.1371/journal.pone.0078472.
The C terminus of p53 regulates gene expression by multiple mechanisms in a target- and tissue-specific manner in vivo.
Hamard P, Barthelery N, Hogstad B, Mungamuri S, Tonnessen C, Carvajal L
Genes Dev. 2013; 27(17):1868-85.
PMID: 24013501
PMC: 3778241.
DOI: 10.1101/gad.224386.113.
Molecular basis for modulation of the p53 target selectivity by KLF4.
Brandt T, Townsley F, Teufel D, Freund S, Veprintsev D
PLoS One. 2012; 7(10):e48252.
PMID: 23118962
PMC: 3484126.
DOI: 10.1371/journal.pone.0048252.
Molecular dynamic simulation insights into the normal state and restoration of p53 function.
Fu T, Min H, Xu Y, Chen J, Li G
Int J Mol Sci. 2012; 13(8):9709-9740.
PMID: 22949826
PMC: 3431824.
DOI: 10.3390/ijms13089709.
Mutant p53: one name, many proteins.
Freed-Pastor W, Prives C
Genes Dev. 2012; 26(12):1268-86.
PMID: 22713868
PMC: 3387655.
DOI: 10.1101/gad.190678.112.
p53 basic C terminus regulates p53 functions through DNA binding modulation of subset of target genes.
Hamard P, Lukin D, Manfredi J
J Biol Chem. 2012; 287(26):22397-407.
PMID: 22514277
PMC: 3381199.
DOI: 10.1074/jbc.M111.331298.
